The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone

Background. Liraglutide leading to improve not only glycaemic control but also liver inflammation in non-alcoholic fatty liver disease (NAFLD) patients. Aims. The aim of this study is to elucidate the effectiveness of liraglutide in NAFLD patients with type 2 diabetes mellitus (T2DM) compared to sit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohki, Takamasa, Isogawa, Akihiro, Iwamoto, Masahiko, Ohsugi, Mitsuru, Yoshida, Haruhiko, Toda, Nobuo, Tagawa, Kazumi, Omata, Masao, Koike, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425807/
https://www.ncbi.nlm.nih.gov/pubmed/22927782
http://dx.doi.org/10.1100/2012/496453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425807/
https://www.ncbi.nlm.nih.gov/pubmed/22927782
http://dx.doi.org/10.1100/2012/496453

Ejemplares similares